StemCells (STEM) surges 18% premarket after yesterday saying its HuCNS-SC treatment restored...

|By:, SA News Editor

StemCells (STEM) surges 18% premarket after yesterday saying its HuCNS-SC treatment restored sensation in two out of three patients who were left paralyzed by severe spinal cord injuries. The developments, which came in a Phase I/II trial, represent "the first time that neural stem cells have been transplanted as a potential therapeutic agent for spinal cord injury." (PR)